NEW YORK, Sept. 25, 2008 (GLOBE NEWSWIRE) -- SIGA Technologies (Nasdaq:SIGA), a company specializing in the development of pharmaceutical agents to fight bio-warfare pathogens, today announced that Dr. Dennis E. Hruby, Chief Scientific Officer, will be participating as an outside expert in the committee evaluating the research and development work recommended in the Institute of Medicine’s 1999 report, Assessment of Future Scientific Needs for Live Variola Virus.
